Concord Wealth Partners - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 1 filers reported holding PEAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$12,980
-35.1%
11,000
+10.0%
0.00%
-33.3%
Q3 2022$20,000
+81.8%
10,000
+42.9%
0.01%
+100.0%
Q2 2022$11,000
+83.3%
7,000
+600.0%
0.00%
+200.0%
Q4 2021$6,0001,0000.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Arboretum Ventures, Inc. 10,859,050$67,326,00038.78%
5AM Venture Management, LLC 18,631,771$115,517,00021.68%
TB Alternative Assets Ltd. 2,071,865$12,846,0003.80%
Palantir Technologies Inc. 1,000,000$6,200,0002.81%
SB Global Advisers Ltd 12,100,078$75,020,0001.49%
EDBI Pte Ltd 426,371$2,644,0001.44%
Temasek Holdings (Private) Ltd 26,803,573$166,182,0000.60%
Alpine Global Management, LLC 625,134$3,876,0000.57%
Blue Water Life Science Advisors, LP 194,686$1,207,0000.37%
Sarissa Capital Management LP 500,356$3,102,0000.27%
View complete list of PEAR THERAPEUTICS INC shareholders